Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
July 22, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the...
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
July 22, 2024 08:30 ET
|
NANO Nuclear Energy Inc.
Tiktinsky's nearly 40 years of experience at the U.S. Nuclear Regulatory Commission to greatly assist NANO Nuclear in navigating the complex U.S. nuclear licensing process New York, N.Y., July 22,...
HeartCore to Authorize Second Dividend Payment
July 22, 2024 08:30 ET
|
HeartCore Enterprises Inc.
NEW YORK and TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based...
Open Lending to Announce Second Quarter 2024 Results on August 8, 2024
July 22, 2024 08:30 ET
|
Open Lending Corporation
AUSTIN, Texas, July 22, 2024 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry trailblazer in automotive lending enablement and risk...
Willis Lease Finance Corporation Hires SR Technics Veteran, Caroline M. Vandedrinck, to Run its Growing Services Businesses
July 22, 2024 08:29 ET
|
Willis Lease Finance Corp.
COCONUT CREEK, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and global...
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
July 22, 2024 08:20 ET
|
SciSparc Ltd
The discovery was demonstrated by utilizing genetic manipulations and 3D spheroid systems, mimicking the main features of human solid tumors TEL AVIV, Israel, July 22, 2024 (GLOBE NEWSWIRE) -- ...
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
July 22, 2024 08:10 ET
|
MiMedx Group, Inc
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM and LHACM allografts on the fibrotic process Marks MIMEDX’s first...
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
July 22, 2024 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...
Franklin Electric Declares Quarterly Dividend of $0.25 Per Share
July 22, 2024 08:00 ET
|
Franklin Electric Co., Inc.
FORT WAYNE, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.25 per share...
Saudi Arabia’s General Authority of Civil Aviation and Lilium sign MoU to collaborate on development and implementation of eVTOL regulation in the Kingdom
July 22, 2024 08:00 ET
|
Lilium GmbH
GACA, Saudi Arabia’s civil aviation regulator, and Lilium agree on a joint regulatory approach for eVTOL regulationThis includes the implementation of a joint Working Group covering all relevant...